REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that its laboratory has been awarded accreditation by the College of American Pathologists (CAP). The company’s gene expression-based Pathwork Tissue of Origin Test, offered by the Pathwork Diagnostics Laboratory, helps identify the origin of metastatic and poorly differentiated tumors and increases pathologists’ and oncologists’ confidence in the cancer diagnosis.
“The CAP Laboratory Accreditation Program is the gold standard for laboratory accreditation with standards exceeding those set by the federal government,” explained pathologist Dr. Samuel Caughron, Director of Molecular Pathology, MAWD Pathology Group, North Kansas City, MO. “CAP accreditation of the Pathwork Diagnostics Laboratory assures patients and physicians that specimens sent for the Tissue of Origin Test are processed with meticulous quality control and in accord with best established practices for laboratory medicine.”
In addition, the Centers for Medicare & Medicaid Services (CMS) has certified the Pathwork Diagnostics Laboratory through its Clinical Laboratory Improvement Amendments (CLIA) program. In 2010, the Pathwork Diagnostics Laboratory received a clinical laboratory permit from the New York State Department of Health, establishing the Tissue of Origin Test as the only FDA-cleared tissue of origin testing service available in New York State. The Pathwork Tissue of Origin Test was also recently endorsed by the Florida Society of Clinical Oncology (FLASCO).
Requiring very small amounts of FFPE tumor tissue, the Tissue of Origin Test measures the gene expression levels in more than 2,000 genes and compares the gene expression pattern of the specimen to that of 15 tissues in the test database, to indicate the most likely match. The Pathwork Tissue of Origin Test is the only FDA-cleared molecular diagnostic test for tissue of origin and the most rigorously validated test of its kind. To have a specimen processed by the Pathwork Diagnostics Laboratory using the Tissue of Origin Test or to learn more about the service, call Pathwork Diagnostics at (877) 808-0006 or visit www.pathworkdx.com.
About Pathwork Diagnostics
Pathwork Diagnostics, Inc. is a privately held company based in Redwood City, CA, that develops and commercializes high-value molecular diagnostics for oncology. For more information call toll-free (877) 808-0006 or visit www.pathworkdx.com.